logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 4
  • 1
    Cresniov, Alexei
    Director born in September 1988
    Individual (3 offsprings)
    Officer
    2020-11-02 ~ 2022-10-05
    OF - Director → CIF 0
  • 2
    Inkster, Ian James, Mr.
    Born in November 1983
    Individual (9 offsprings)
    Officer
    2021-08-02 ~ now
    OF - Director → CIF 0
  • 3
    Buvailo, Andrii, Dr
    Director born in February 1985
    Individual (2 offsprings)
    Officer
    2020-11-02 ~ 2021-12-30
    OF - Director → CIF 0
  • 4
    DEEP KNOWLEDGE ANALYTICS LIMITED
    11384176
    85, Great Portland Street, London, England
    Active Corporate (4 parents, 2 offsprings)
    Person with significant control
    2020-11-02 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

DEEP PHARMA INTELLIGENCE LTD

Period: 2020-11-02 ~ now
Company number: 12987888
Registered name
DEEP PHARMA INTELLIGENCE LTD - now
Standard Industrial Classification
62090 - Other Information Technology Service Activities
Brief company account
Intangible Assets
294,233 GBP2025-03-31
294,233 GBP2024-03-31
Fixed Assets
294,233 GBP2025-03-31
294,233 GBP2024-03-31
Debtors
4,795 GBP2025-03-31
4,933 GBP2024-03-31
Cash at bank and in hand
2,392 GBP2025-03-31
151 GBP2024-03-31
Current Assets
7,187 GBP2025-03-31
5,084 GBP2024-03-31
Net Current Assets/Liabilities
-339,960 GBP2025-03-31
-313,161 GBP2024-03-31
Total Assets Less Current Liabilities
-45,727 GBP2025-03-31
-18,928 GBP2024-03-31
Net Assets/Liabilities
-45,727 GBP2025-03-31
-18,928 GBP2024-03-31
Equity
Called up share capital
10,000 GBP2025-03-31
10,000 GBP2024-03-31
Retained earnings (accumulated losses)
-55,727 GBP2025-03-31
-28,928 GBP2024-03-31
Average Number of Employees
12024-04-01 ~ 2025-03-31
12023-04-01 ~ 2024-03-31
Intangible Assets - Gross Cost
Development expenditure
326,926 GBP2025-03-31
326,926 GBP2024-03-31
Intangible Assets - Accumulated Amortisation & Impairment
Development expenditure
32,693 GBP2025-03-31
32,693 GBP2024-03-31
Intangible Assets
Development expenditure
294,233 GBP2025-03-31
294,233 GBP2024-03-31
Trade Debtors/Trade Receivables
Current
3,350 GBP2025-03-31
3,418 GBP2024-03-31
Trade Creditors/Trade Payables
Current
12,844 GBP2025-03-31
12,735 GBP2024-03-31
Other Taxation & Social Security Payable
Current
-18,736 GBP2025-03-31
-18,666 GBP2024-03-31

  • DEEP PHARMA INTELLIGENCE LTD
    Info
    Registered number 12987888
    167-169 Great Portland Street, Fifth Floor, London W1W 5PF
    PRIVATE LIMITED COMPANY incorporated on 2020-11-02 (5 years 6 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-09-14
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 5 April 2026 and licensed under the Open Government Licence v3.0.